DIFFERENCES IN THE EXPRESSION OF CD184, CD95, CD178 AND CD40 IN HUMAN GLIOMAS OF VARIOUS GRADES, BEFORE AND AFTER CHEMOTHERAPY

被引：0
|
作者：
Werner, Jan [1 ]
Roehn, Gabriele [1 ]
Goldbrunner, Roland [1 ]
Timmer, Marco [1 ]
机构：
[1] Univ Hosp Cologne, Dept Gen Neurosurg, Ctr Neurosurg, Cologne, Germany
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
10.1093/neuonc/nou257.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IB-13
引用
收藏
页数：1
相关论文
共 50 条
  • [1] DIFFERENCES IN THE EXPRESSION OF CD184, CD95, CD178 AND CD40 IN HUMAN GLIOMAS OF VARIOUS GRADES, BEFORE AND AFTER CHEMOTHERAPY
    Werner, J.
    Roehn, G.
    Breuer, N.
    Goldbrunner, R.
    Timmer, M.
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [2] Fas (CD95)/FasL (CD178) system during ageing
    Lagunas-Rangel, Francisco A.
    [J]. CELL BIOLOGY INTERNATIONAL, 2023, 47 (08) : 1295 - 1313
  • [3] Differential expression of CD40 and CD95 in ovarian carcinoma
    Ciaravino, G
    Bhat, M
    Manbeian, CA
    Teng, NNH
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (01) : 27 - 32
  • [4] Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians
    M Pinti
    L Troiano
    M Nasi
    L Moretti
    E Monterastelli
    A Mazzacani
    C Mussi
    P Ventura
    F Olivieri
    C Franceschi
    G Salvioli
    A Cossarizza
    [J]. Cell Death & Differentiation, 2002, 9 : 431 - 438
  • [5] Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians
    Pinti, M
    Troiano, L
    Nasi, M
    Moretti, L
    Monterastelli, E
    Mazzacani, A
    Mussi, C
    Ventura, P
    Olivieri, F
    Franceschi, C
    Salvioli, G
    Cossarizza, A
    [J]. CELL DEATH AND DIFFERENTIATION, 2002, 9 (04): : 431 - 438
  • [6] Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178)
    Ghadimi, MP
    Sanzenbacher, R
    Thiede, B
    Wenzel, J
    Jing, Q
    Plomann, M
    Borkhardt, A
    Kabelitz, D
    Janssen, O
    [J]. FEBS LETTERS, 2002, 519 (1-3) : 50 - 58
  • [7] Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients
    Marín, LA
    Muro, M
    Moya-Quiles, MR
    Miras, M
    Minguela, A
    Bermejo, J
    Sanchez-Bueno, F
    Parrilla, P
    Alvarez-López, MR
    [J]. TISSUE ANTIGENS, 2006, 67 (02): : 117 - 126
  • [8] Expression of Fas (CD95) and CD40 in human prostatic carcinoma cell lines.
    Rokhlin, O
    Bishop, G
    Hostager, B
    Sidorenko, S
    Cohen, M
    [J]. FASEB JOURNAL, 1996, 10 (06): : 2006 - 2006
  • [9] Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo-1) and Fas Ligand (CD178) expression
    Salih, HR
    Starling, GC
    Brandl, SF
    Pelka-Fleischer, R
    Haferlach, T
    Hiddemann, W
    Kiener, PA
    Nuessler, V
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (01) : 76 - 85
  • [10] Arachidonic acid metabolism in TNF, CD178 (CD95 ligand) and ceramide-mediated cytotoxicity
    Oldak, Monika
    Jozwiak, Jaroslaw
    Maksym, Radoslaw
    Malejczyk, Jacek
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2007, 3 (01): : 27 - 30
12345